Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In premenopausal women with idiopathic osteoporosis (IOP), treatment with teriparatide leads to substantial improvement in bone density and quality at central skeletal sites. The effects of teriparatide may differ on cortical and trabecular bone and also at the central and the peripheral skeleton.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Clin. Endocrinol. Metab.

Title: The Journal of clinical endocrinology and metabolism

Publisher: The Endocrine Society

ISSN (Electronic): 1945-7197

ISSN (Print): 0021-972X

Publication date (Electronic): Jul 2014

Volume: 99

Issue: 7

Affiliations

[1 ] Division of Endocrinology (K.K.N., A.C., P.Y., E.S.), Department of Medicine, and Department of Pathology (D.W.D.), College of Physicians and Surgeons, Columbia University, New York, New York 10032; Department of Biomedical Engineering (J.W., X.E.G.), Columbia University, New York, New York 10027; and Division of Endocrinology (J.M.L., R.R.R.), Department of Medicine, Creighton University, Omaha, Nebraska 68131.

Article

DOI: 10.1210/jc.2014-1041

PMC ID: 4079304

PubMed ID: 24684466

SO-VID: c4b54006-f342-4854-9dee-4165e7626b92

History

Data availability:

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Cited by 21

See all cited by